[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100524525":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":30,"responsibleParty":47,"collaborators":10,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":10,"eligibilityCriteria":54,"healthyVolunteers":51,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Patients undergo blood and urine sample collection and have their medical records reviewed while on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Non-Interventional Study","Non-interventional study",[9],[20],{"name":21,"affiliation":22,"role":23},"John B. Kisiel, MD","Mayo Clinic in Rochester","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Clinical Trials Referral Office","CONTACT","855-776-0015","mayocliniccancerstudies@mayo.edu",[31],{"facility":22,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-92.4699,44.02163,{"lat":42,"lon":41},[45,46],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},{"name":21,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100524525","bladder-bank-a-prospective-banking-study-100524525",false,"NCT06109857","Bladder Bank (a Prospective Banking Study)","Inclusion Criteria:\n\n* Age \\> 18 years\n* Patient has undergone office-based evaluation for hematuria \\[computed tomography (CT), ultrasound, cystoscopy\\]\n\nExclusion Criteria:\n\n* Patient has known cancer outside of the target cancer 5 years prior to current collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible)\n* Patient has recurrent muscle invasive bladder cancer\n* Patient has ever been previously diagnosed with UTUC (upper tract urothelial carcinoma) prior to bladder resection\n* Patient has received chemotherapy class drugs for the treatment of non-target origin cancer in the 5 years prior to current collection\n* Patient has had any prior radiation therapy to the target lesion prior to current collection\n* Patient has had a biopsy to the target organ and\u002For lesion within 3 days before collection\n* Patient has undergone cystectomy or cystoprostatectomy\n* Patient has transurethral instrumentation (placement of urinary catheter) within 7 days prior to urine collection\n* Patient has had a urinary tract infection within 14 days prior to urine collection\n* Patient has chronic indwelling urinary catheter","ALL","18 Years",{"count":58,"type":59},1500,"ESTIMATED","OBSERVATIONAL","This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.",[63],"Bladder Carcinoma","2026-03-12",{"date":66,"type":67},"2026-03-16","ACTUAL",{"date":69,"type":67},"2022-07-06",{"date":71,"type":59},"2027-12-01",{"name":5,"class":6},1]